Results 231 to 240 of about 21,878,726 (386)
Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance
Cellular heterogeneity is a major cause of drug resistance in cancer. Segeren et al. used single‐cell transcriptomics to investigate gene expression events that correlate with sensitivity to the DNA‐damaging drugs gemcitabine and prexasertib. They show that dampened expression of transcription factor FOXM1 and its target genes protected cells against ...
Hendrika A. Segeren+4 more
wiley +1 more source
The magnitude and associated factors of childhood cancer treatment abandonment at the university of Gondar comprehensive specialized hospital, Ethiopia. [PDF]
Molla YM, Shad A, Wali R, Yimer MA.
europepmc +1 more source
The study evaluated the function and therapeutic implications of PRAME in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The findings demonstrate that PRAME impairs keratinocyte differentiation pathways. Furthermore, PRAME impairs anticancer response to retinoid compounds in BCC and SCC cells.
Brandon Ramchatesingh+6 more
wiley +1 more source
Physiological regulation underlying the alleviation of cadmium stress in maize seedlings by exogenous glycerol. [PDF]
Li Q+7 more
europepmc +1 more source
TOTAL THYROIDECTOMY IN THE TREATMENT OF PATIENTS WITH CONGESTIVE HEART FAILURE AND ANGINA PECTORIS [PDF]
Ori Brenner+2 more
openalex +1 more source
CircCCNB1 expression is down‐regulated in nasopharyngeal carcinoma (NPC); thus, less NF90 protein is bound to circCCNB1 and more binds to pri‐miRNAs, blocking their (pri‐miRNAs) binding to DGCR8 and inhibiting the processing and generation of miR‐15b‐5p/miR‐7‐1‐3p. Furthermore, decreased miR‐15b‐5p/miR‐7‐1‐3p promotes the expression of the target genes
Chunmei Fan+6 more
wiley +1 more source
Clinical efficacy of azacitidine in the treatment of middle- and high-risk myelodysplastic syndrome in middle-aged and elderly patients: A retrospective study. [PDF]
Li L, Bian J, Su Y, Zhang C.
europepmc +1 more source
OPERATIVE TREATMENT OF PARALYTIC GENU RECURVATUM
Willis C. Campbell, Joseph I. Mitchell
openalex +2 more sources